Works matching AU Scheen, A J

Results: 99

Drug interactions of clinical importance with antihyperglycaemic agents: an update.

Published in:

2005

By:

Scheen, André J.;
Scheen, André J

Publication type:

journal article

Diabetes is still a risk factor for restenosis after drug-eluting stent in coronary arteries.

Published in:

2004

By:

Scheen, Andre J.;
Warzée, Fabian;
Scheen, André J;
Warzée, Fabian

Publication type:

commentary

Pharmacokinetic interactions with thiazolidinediones.

Published in:

2007

By:

Scheen, André J.;
Scheen, André J

Publication type:

journal article

Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide.

Published in:

2007

By:

Scheen, André J.;
Scheen, André J

Publication type:

journal article

Antiobesity pharmacotherapy in the management of type 2 diabetes.

Published in:

2000

By:

Scheen, André J.;
Lefèbvre, Pierre J.;
Scheen, A J;
Lefèbvre, P J

Publication type:

journal article

Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine.

Published in:

1991

By:

Scheen, André J.;
Paolisso, Giuseppe;
Salvatore, Teresa;
Lefèbvre, Pierre J.;
Scheen, A J;
Paolisso, G;
Salvatore, T;
Lefèbvre, P J

Publication type:

journal article

Decreased or increased insulin metabolism after glipizide in type II diabetes.

Published in:

1988

By:

Scheen, André J;
Castillo, Manuel J.;
Lefèbvre, Pierre J.;
Scheen, A J;
Castillo, M J;
Lefèbvre, P J

Publication type:

Letter

U-100 insulin gives some protection against metabolic deterioration due to CSII interruption.

Published in:

1987

By:

Scheen, André J.;
Henrivaux, Philippe;
Jandrain, Bernard;
Lefèbvre, Pierre J.;
Scheen, A J;
Henrivaux, P;
Jandrain, B;
Lefèbvre, P J

Publication type:

journal article

Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII.

Published in:

1987

By:

Scheen, André J.;
Henrivaux, Philippe;
Jandrain, Bernard;
Paolisso, Giuseppe;
Lefebvre, Pierre J.;
Scheen, A J;
Henrivaux, P;
Jandrain, B;
Paolisso, G;
Lefèbvre, P J

Publication type:

journal article

Inhibiting or antagonizing glucagon: making progress in diabetes care.

Published in:

Diabetes, Obesity & Metabolism, 2015, v. 17, n. 8, p. 720, doi. 10.1111/dom.12480

By:

Lefèbvre, P. J.;
Paquot, N.;
Scheen, A. J.

Publication type:

Article

Pharmacokinetics of dipeptidylpeptidase-4 inhibitors.

Published in:

Diabetes, Obesity & Metabolism, 2010, v. 12, n. 8, p. 648, doi. 10.1111/j.1463-1326.2010.01212.x

By:

Scheen, A. J.

Publication type:

Article

Controversy about the cardiovascular safety of sibutramine.

Published in:

2010

By:

Scheen AJ;
Scheen, André J

Publication type:

journal article

Drug Interactions of Clinical Importance with Antihyperglycaemic Agents : An Update.

Published in:

2005

By:

Scheen, André J

Publication type:

journal article

Tolerability Profile of Metformin/Glibenclamide Combination Tablets (Glucovance®): A New Treatment for the Management of Type 2 Diabetes Mellitus.

Published in:

Drug Safety, 2004, v. 27, n. 15, p. 1205, doi. 10.2165/00002018-200427150-00004

By:

Davidson, Jaime A.;
Scheen, André J.;
Howlett, Harry C.S.

Publication type:

Article

Combined thiazolidinedione-insulin therapy: should we be concerned about safety?

Published in:

2004

By:

Scheen, André J

Publication type:

journal article

Combined Thiazolidinedione-Insulin Therapy.

Published in:

Drug Safety, 2004, v. 27, n. 12, p. 841, doi. 10.2165/00002018-200427120-00002

By:

Scheen, André J.

Publication type:

Article

Intact cross-talk between insulin secretion and insulin action after postgastroplasty recovery of ideal body weight in severely obese patients.

Published in:

2004

By:

Letiexhe, M. R.;
Desaive, C.;
Lefébvre, P. J.;
Scheen, A. J.

Publication type:

Cover Art

Assessment of postprandial hepatic glycogen synthesis from uridine diphosphoglucose kinetics in obese and lean non-diabetic subjects.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2000, v. 24, n. 10, p. 1297, doi. 10.1038/sj.ijo.0801386

By:

Paquot, N;
Schneiter, Ph;
Scheen, A J;
Lefèbvre, P J;
Tappy, L

Publication type:

Article

Foreword.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2000, v. 24, p. S1, doi. 10.1038/sj.ijo.0801322

By:

Van Gaal, Luc F;
Scheen, Andre J

Publication type:

Article

Dapagliflozin: A Review of its Use in Type 2 Diabetes Mellitus.

Published in:

2012

By:

Plosker, Greg L.;
Cheung, B. M.;
Cucinotta, D.;
Nilsson, P. M.;
Penfornis, A.;
Scheen, A. J.

Publication type:

Journal Article

Careful use to minimize adverse events of oral antidiabetic medications in the elderly.

Published in:

Expert Opinion on Pharmacotherapy, 2021, v. 22, n. 16, p. 2149, doi. 10.1080/14656566.2021.1912735

By:

Scheen, André J.

Publication type:

Article

Preventing and treating kidney disease in patients with type 2 diabetes.

Published in:

Expert Opinion on Pharmacotherapy, 2019, v. 20, n. 3, p. 277, doi. 10.1080/14656566.2018.1551362

By:

Delanaye, Pierre;
Scheen, André J.

Publication type:

Article

Pharmacotherapy of ‘treatment resistant’ type 2 diabetes.

Published in:

Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 5, p. 503, doi. 10.1080/14656566.2017.1297424

By:

Scheen, André J.

Publication type:

Article

Effect of SGLT2 Inhibitors on the Sympathetic Nervous System and Blood Pressure.

Published in:

Current Cardiology Reports, 2019, v. 21, n. 8, p. N.PAG, doi. 10.1007/s11886-019-1165-1

By:

Scheen, André J.

Publication type:

Article

Pharmacological treatment of obesity: present status.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 1999, v. 23, p. s47, doi. 10.1038/sj.ijo.0800795

By:

Scheen, A J;
Lefebvre, P J

Publication type:

Article

Influence of the A→G (-3826) uncoupling protein-1 gene (UCP1) variant on the dynamics of body weight before and after gastroplasty in morbidly obese subjects.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 1998, v. 22, n. 12, p. 1244, doi. 10.1038/sj.ijo.0800775

By:

Luyckx, F H;
Scheen, A J;
Proenza, A M;
Strosberg, A D;
Lefèbvre, P J;
Gielen, J E

Publication type:

Article

Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 1998, v. 22, n. 3, p. 222, doi. 10.1038/sj.ijo.0800571

By:

Luyckx, F H;
Desaive, C;
Thiry, A;
Dewé, W;
Scheen, A J;
Gielen, J E;
Lefèbvre, P J

Publication type:

Article

Devices for the Treatment of Diabetes: Today.

Published in:

Artificial Organs, 1992, v. 16, n. 2, p. 163, doi. 10.1111/j.1525-1594.1992.tb00287.x

By:

Scheen, Andre J.

Publication type:

Article

Changes in pulse pressure, heart rate and the pulse pressure × heart rate product during squatting in Type 1 diabetes according to age.

Published in:

Diabetic Medicine, 2010, v. 27, n. 7, p. 753, doi. 10.1111/j.1464-5491.2010.03018.x

By:

Philips, J.-C.;
Marchand, M.;
Scheen, A. J.

Publication type:

Article

Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18).

Published in:

Diabetic Medicine, 2009, v. 26, n. 12, p. 1242, doi. 10.1111/j.1464-5491.2009.02857.x

By:

Scheen, A. J.;
Tan, M. H.;
Betteridge, D. J.;
Birkeland, K.;
Schmitz, O.;
Charbonnel, B.

Publication type:

Article

Long-term glycaemic control with metformin–sulphonylurea–pioglitazone triple therapy in PROactive (PROactive 17).

Published in:

Diabetic Medicine, 2009, v. 26, n. 10, p. 1033, doi. 10.1111/j.1464-5491.2009.02816.x

By:

Scheen, A. J.;
Tan, M. H.;
Betteridge, D. J.;
Birkeland, K.;
Schmitz, O.;
Charbonnel, B.

Publication type:

Article

SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2020, v. 13, p. 2765, doi. 10.2147/DMSO.S193528

By:

Scheen, André J

Publication type:

Article

Will delayed release metformin provide better management of diabetes type 2?

Published in:

2016

By:

Scheen, André J.

Publication type:

Editorial

Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes.

Published in:

Expert Opinion on Investigational Drugs, 2017, v. 26, n. 12, p. 1373, doi. 10.1080/13543784.2017.1395020

By:

Scheen, André J.;
Paquot, Nicolas;
Lefèbvre, Pierre J.

Publication type:

Article

Investigational insulin secretagogues for type 2 diabetes.

Published in:

Expert Opinion on Investigational Drugs, 2016, v. 25, n. 4, p. 405, doi. 10.1517/13543784.2016.1152260

By:

Scheen, André J.

Publication type:

Article

Underuse of GLP-1 receptor agonists in the management of type 2 diabetes despite a favorable benefit-safety profile.

Published in:

Expert Opinion on Drug Safety, 2024, v. 23, n. 7, p. 797, doi. 10.1080/14740338.2024.2354885

By:

Scheen, André J.

Publication type:

Article

Aspirin and clopidogrel resistance in patients with diabetes mellitus.

Published in:

European Heart Journal, 2006, v. 27, n. 23, p. 2900, doi. 10.1093/eurheartj/ehl295

By:

Scheen, André J.;
Legrand, Delphine

Publication type:

Article

Drug-eluting stents: meta-analysis in diabetic patients.

Published in:

European Heart Journal, 2004, v. 25, n. 23, p. 2167, doi. 10.1016/j.ehj.2004.07.041

By:

Scheen, André J.;
Warzée, Fabian;
Legrand, Victor M.G.

Publication type:

Article

Poor Glycemic Control Is a Major Factor in the Overestimation of Glomerular Filtration Rate in Diabetic Patients. Diabetes Care 2014;37:596-603.

Published in:

2014

By:

Delanaye, Pierre;
Scheen, André J.

Publication type:

Letter to the Editor

Sibutramine on cardiovascular outcome.

Published in:

2011

By:

Scheen, André J

Publication type:

journal article

Sibutramine on Cardiovascular Outcome.

Published in:

Diabetes Care, 2011, v. 34, p. S114, doi. 10.2337/dc11-s205

By:

SCHEEN, ANDRE J.

Publication type:

Article

Pulsatile Stress in Middle-Aged Patients With Type 1 or Type 2 Diabetes Compared With Nondiabetic Control Subjects.

Published in:

Diabetes Care, 2010, v. 33, n. 11, p. 2424, doi. 10.2337/dc10-0302

By:

PHILIPS, JEAN-CHRISTOPHE;
MARCHAND, MONIQUE;
SCHEEN, ANDRÉ J.

Publication type:

Article

Squatting Amplifies Pulse Pressure Increase With Disease Duration in Patients With Type 1 Diabetes.

Published in:

Diabetes Care, 2008, v. 31, n. 2, p. 322, doi. 10.2337/dc07-1646

By:

Philips, Jean-Christophe;
Marchand, Monique;
Scheen, André J.

Publication type:

Article

Preventing, Delaying, or Masking Type 2 Diabetes With Metformin in the Diabetes Prevention Program.

Published in:

Diabetes Care, 2003, v. 26, n. 9, p. 2701, doi. 10.2337/diacare.26.9.2701

By:

Scheen, Andre J.

Publication type:

Article

Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents.

Published in:

2002

By:

Scheen, André J;
Lefèbvre, Pierrè J

Publication type:

commentary

Potential Pharmacokinetics Interference Between α-Glucosidase Inhibitors and Other Oral Antidiabetic Agents.

Published in:

Diabetes Care, 2002, v. 25, n. 1, p. 247, doi. 10.2337/diacare.25.1.247

By:

Scheen, Andre J.;
Lefebvre, Pierre J.

Publication type:

Article

Troglitazone: Antihyperglycemic Activity and Potential Role in the Treatment of Type 2 Diabetes.

Published in:

Diabetes Care, 1999, v. 22, n. 9, p. 1568, doi. 10.2337/diacare.22.9.1568

By:

Scheen, Andre J.;
Lefebvre, Pierre J.

Publication type:

Article

CB1 Receptor Blockade and its Impact on Cardiometabolic Risk Factors: Overview of the RIO Programme with Rimonabant.

Published in:

Journal of Neuroendocrinology, 2008, v. 20, p. 139, doi. 10.1111/j.1365-2826.2008.01681.x

By:

Scheen, A. J.

Publication type:

Article

Reduction of the acute bioavailability of metformin by the α-glucosidase inhibitor acarbose in normal man.

Published in:

European Journal of Clinical Investigation, 1994, v. 24, p. 50, doi. 10.1111/j.1365-2362.1994.tb02257.x

By:

SCHEEN, A. J.;
FERREIRA ALVES de MAGALHAES, A. C.;
SALVATORE, T.;
LEFEBVRE, P. J.

Publication type:

Article

The use of acarbose in the prevention and treatment of hypoglycaemia.

Published in:

European Journal of Clinical Investigation, 1994, v. 24, p. 40, doi. 10.1111/j.1365-2362.1994.tb02255.x

By:

LEFEBVRE, P. J.;
SCHEEN, A. J.

Publication type:

Article